MedTrace Logo

The Effect of Sucralfate Slurry in Patients With Eosinophilic Esophagitis

NCT02353078 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2017-10-11

No results posted yet for this study

Summary

Could Sucralfate be a non-steriodal treatment option for patients with Eosinophilic esophagitis?

Conditions

  • Eosinophilic Esophagitis

Interventions

DRUG

Sucralfate

Sucralfate slurry 1 gram four times daily for four weeks

PROCEDURE

Intraluminal Impedance

During the initial endoscopy, esophageal mucosal impedance will also be measured. This procedure involves passing a mucosal impedance probe through the endoscope and gently placing the tip of the probe on the esophageal mucosa. Measurements will be made at 2,5,10 and 15 cm above the gastroesophageal junction. There is no increased risk to the procedure and it adds approximately 2 minutes to the procedure.

DEVICE

Intraluminal Impedance

The mucosal impedance probe is a 2.13 mm catheter (tiny tube), called an Intraluminal Impedance, will be passed through the channel of the standard endoscope. There is no increased risk to the procedure and it adds approximately 2 minutes to the procedure.

Sponsors & Collaborators

Principal Investigators

  • David Katzka, MD · Mayo Clinic

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02353078 on ClinicalTrials.gov